Concepedia

Thomas Lindebo Holm

TL

22

Publications

893

Citations

17

H-Index

2005

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

University of Copenhagen

Herlev Hospital

Copenhagen Business School

Aarhus University

Thomas Lindebo Holm is an author at Novo Nordisk (Denmark) specializing in medicine, inflammation, and immunology.

ORCID

Top concepts

Publications per year

2005–2021

22

Publications

22

IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma

Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A. Freeman et al. · Cancer Immunology Immunotherapy · 2008 · 114 citations · Full text

GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation

Claus Heiner Bang‐Berthelsen, Thomas Lindebo Holm, Charles Pyke et al. · Inflammatory Bowel Diseases · 2016 · 97 citations

A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice

Jacob Lund, Per Greisen, Stine Kjellev et al. · Blood · 2021 · 74 citations · Full text

High-Resolution Gene Expression Profiling Using RNA Sequencing in Patients With Inflammatory Bowel Disease and in Mouse Models of Colitis

Kristine Holgersen, Burak Kutlu, Brian A. Fox et al. · Journal of Crohn s and Colitis · 2015 · 70 citations

In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells Expressing<i>Foxp3</i>

Dorthe Lundsgaard, Thomas Lindebo Holm, Lars Hornum et al. · Diabetes · 2005 · 58 citations · Full text

Rows per page

1–5 of 22